Salarius Pharmaceuticals
SLRX
SLRX
11 hedge funds and large institutions have $186K invested in Salarius Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$29.5K |
| 2 |
2
Morgan Stanley
New York
|
$115 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
HKAM
1
Horizon Kinetics Asset Management
New York
| $61.9K | 32,400 | +32,400 | New |
|
2
Renaissance Technologies
New York
| $38K | 20,042 | +3,700 | +23% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $31.7K | 16,523 | – | – |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $29.5K | 15,420 | -22,734 | -60% |
|
5
Two Sigma Investments
New York
| $19.8K | 10,370 | +10,370 | New |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $2.65K | 1,387 | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $2.15K | 1,126 | +887 | +371% |
|
|
8
Morgan Stanley
New York
| $115 | 60 | -3 | -5% |
|
9
BlackRock
New York
| $90 | 47 | – | – |
|
10
Fidelity Investments
Boston,
Massachusetts
| $90 | 47 | +47 | New |
|
11
Wells Fargo
San Francisco,
California
| $29 | 15 | – | – |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | – | -533 | Closed |
|
|
CFGS
13
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|